| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | syntaxin-1 binding | 7.91e-06 | 24 | 108 | 4 | GO:0017075 | |
| GeneOntologyMolecularFunction | phorbol ester receptor activity | 2.90e-05 | 2 | 108 | 2 | GO:0001565 | |
| GeneOntologyMolecularFunction | non-kinase phorbol ester receptor activity | 2.90e-05 | 2 | 108 | 2 | GO:0001566 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CACNB2 MYH11 MID2 GIT1 NEIL2 SPTA1 SPTB CAPN3 ARPC2 SPTBN5 S100A8 LLGL2 MACO1 KCNMA1 DIXDC1 FERMT2 MLPH | 8.26e-05 | 1099 | 108 | 17 | GO:0008092 |
| GeneOntologyMolecularFunction | 11-cis-retinol dehydrogenase activity | 8.66e-05 | 3 | 108 | 2 | GO:0102354 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.36e-04 | 227 | 108 | 7 | GO:0051015 | |
| GeneOntologyMolecularFunction | actin binding | CACNB2 MYH11 SPTA1 SPTB ARPC2 SPTBN5 KCNMA1 DIXDC1 FERMT2 MLPH | 2.73e-04 | 479 | 108 | 10 | GO:0003779 |
| GeneOntologyMolecularFunction | calcium ion sensor activity | 5.98e-04 | 7 | 108 | 2 | GO:0061891 | |
| GeneOntologyMolecularFunction | cAMP-dependent protein kinase activity | 5.98e-04 | 7 | 108 | 2 | GO:0004691 | |
| GeneOntologyMolecularFunction | phospholipid binding | 7.79e-04 | 548 | 108 | 10 | GO:0005543 | |
| GeneOntologyMolecularFunction | metal ion sensor activity | 7.94e-04 | 8 | 108 | 2 | GO:0140784 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 8.15e-04 | 34 | 108 | 3 | GO:0050750 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 9.24e-04 | 138 | 108 | 5 | GO:0016614 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-dependent protein kinase activity | 1.02e-03 | 9 | 108 | 2 | GO:0004690 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 1.02e-03 | 9 | 108 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 1.02e-03 | 9 | 108 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 1.22e-03 | 39 | 108 | 3 | GO:0070325 | |
| GeneOntologyMolecularFunction | syntaxin binding | 1.28e-03 | 87 | 108 | 4 | GO:0019905 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.52e-03 | 42 | 108 | 3 | GO:0098918 | |
| GeneOntologyMolecularFunction | small GTPase binding | 1.81e-03 | 321 | 108 | 7 | GO:0031267 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.97e-03 | 46 | 108 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 2.17e-03 | 13 | 108 | 2 | GO:0098879 | |
| GeneOntologyMolecularFunction | magnesium ion binding | 2.26e-03 | 247 | 108 | 6 | GO:0000287 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of polarity of embryonic epithelium | 1.25e-07 | 3 | 104 | 3 | GO:0016332 | |
| GeneOntologyCellularComponent | neuron projection terminus | UNC13B GIT1 ARPC2 MACO1 KCNMA1 SYT1 RIMBP2 UNC13C DIXDC1 AP3D1 | 3.33e-07 | 233 | 107 | 10 | GO:0044306 |
| GeneOntologyCellularComponent | spectrin | 1.07e-05 | 9 | 107 | 3 | GO:0008091 | |
| GeneOntologyCellularComponent | axon terminus | 1.26e-05 | 210 | 107 | 8 | GO:0043679 | |
| GeneOntologyCellularComponent | cell cortex | UNC13B SPTA1 SPTB SPTBN5 LLGL2 RIMBP2 UNC13C FERMT2 GPSM1 MLPH | 2.10e-05 | 371 | 107 | 10 | GO:0005938 |
| GeneOntologyCellularComponent | calyx of Held | 3.37e-05 | 36 | 107 | 4 | GO:0044305 | |
| GeneOntologyCellularComponent | cell cortex region | 8.22e-05 | 45 | 107 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | presynaptic active zone | 8.75e-05 | 141 | 107 | 6 | GO:0048786 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.16e-04 | 93 | 107 | 5 | GO:0030864 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH11 SPTA1 SPTB DAPK1 CDC42BPB ARPC2 SPTBN5 LLGL2 DIXDC1 FERMT2 MLPH | 1.79e-04 | 576 | 107 | 11 | GO:0015629 |
| GeneOntologyCellularComponent | axon | UNC13B GIT1 SPTA1 ARPC2 PALS1 SHANK2 SACS MACO1 KCNMA1 SYT1 RIMBP2 UNC13C DIXDC1 AP3D1 | 1.80e-04 | 891 | 107 | 14 | GO:0030424 |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 2.14e-04 | 23 | 107 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | glutamatergic synapse | UNC13B GIT1 SPTB DAPK1 GPC6 SLC1A6 ARPC2 SHANK2 KCNMA1 SYT1 RIMBP2 DIXDC1 AP3D1 | 2.76e-04 | 817 | 107 | 13 | GO:0098978 |
| GeneOntologyCellularComponent | actomyosin | 3.40e-04 | 117 | 107 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | ATP-binding cassette (ABC) transporter complex | 3.84e-04 | 6 | 107 | 2 | GO:0043190 | |
| GeneOntologyCellularComponent | distal axon | 4.00e-04 | 435 | 107 | 9 | GO:0150034 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 5.32e-04 | 129 | 107 | 5 | GO:0030863 | |
| GeneOntologyCellularComponent | presynapse | UNC13B CACNB2 GIT1 SLC1A6 ARPC2 SHANK2 KCNMA1 SYT1 RIMBP2 UNC13C DIXDC1 AP3D1 CACNA2D3 | 5.95e-04 | 886 | 107 | 13 | GO:0098793 |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 7.47e-04 | 139 | 107 | 5 | GO:0097733 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 9.13e-04 | 9 | 107 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 1.15e-03 | 153 | 107 | 5 | GO:0097731 | |
| GeneOntologyCellularComponent | terminal bouton | 1.50e-03 | 96 | 107 | 4 | GO:0043195 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 2.00e-03 | 443 | 107 | 8 | GO:0098791 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 2.24e-03 | 107 | 107 | 4 | GO:0097517 | |
| GeneOntologyCellularComponent | excitatory synapse | 2.24e-03 | 107 | 107 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | stress fiber | 2.24e-03 | 107 | 107 | 4 | GO:0001725 | |
| GeneOntologyCellularComponent | Golgi lumen | 2.39e-03 | 109 | 107 | 4 | GO:0005796 | |
| GeneOntologyCellularComponent | photoreceptor outer segment | 2.55e-03 | 111 | 107 | 4 | GO:0001750 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | UNC13B ATP8B3 LPCAT1 ABCA2 GGA2 WNT7B APOB GGA3 ARPC2 SERPINB12 SYT1 UNC13C KIR2DL3 GGA1 AP3D1 | 2.67e-03 | 1307 | 107 | 15 | GO:0030659 |
| GeneOntologyCellularComponent | melanosome | 2.72e-03 | 113 | 107 | 4 | GO:0042470 | |
| GeneOntologyCellularComponent | pigment granule | 2.72e-03 | 113 | 107 | 4 | GO:0048770 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.03e-03 | 277 | 107 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | vesicle membrane | UNC13B ATP8B3 LPCAT1 ABCA2 GGA2 WNT7B APOB GGA3 ARPC2 SERPINB12 SYT1 UNC13C KIR2DL3 GGA1 AP3D1 | 3.04e-03 | 1325 | 107 | 15 | GO:0012506 |
| GeneOntologyCellularComponent | actin filament bundle | 3.18e-03 | 118 | 107 | 4 | GO:0032432 | |
| GeneOntologyCellularComponent | non-motile cilium | 3.38e-03 | 196 | 107 | 5 | GO:0097730 | |
| GeneOntologyCellularComponent | trans-Golgi network | 4.92e-03 | 306 | 107 | 6 | GO:0005802 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 4.93e-03 | 67 | 107 | 3 | GO:0098686 | |
| MousePheno | delayed dark adaptation | 3.10e-05 | 10 | 91 | 3 | MP:0003011 | |
| MousePheno | cerebral infarct | 4.19e-05 | 2 | 91 | 2 | MP:0021003 | |
| MousePheno | low mean erythrocyte cell number | 5.63e-05 | 12 | 91 | 3 | MP:0002594 | |
| Domain | GAE | 1.76e-06 | 5 | 106 | 3 | PS50180 | |
| Domain | - | 3.51e-06 | 6 | 106 | 3 | 2.60.40.1230 | |
| Domain | GAT_dom | 3.51e-06 | 6 | 106 | 3 | IPR004152 | |
| Domain | - | 3.51e-06 | 6 | 106 | 3 | 1.20.58.160 | |
| Domain | Clathrin_g-adaptin_app | 3.51e-06 | 6 | 106 | 3 | IPR008153 | |
| Domain | GAT | 3.51e-06 | 6 | 106 | 3 | PS50909 | |
| Domain | GAT | 3.51e-06 | 6 | 106 | 3 | PF03127 | |
| Domain | Alpha_adaptinC2 | 1.46e-05 | 9 | 106 | 3 | PF02883 | |
| Domain | VHS | 1.46e-05 | 9 | 106 | 3 | PS50179 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 1.46e-05 | 9 | 106 | 3 | IPR008152 | |
| Domain | VHS | 1.46e-05 | 9 | 106 | 3 | PF00790 | |
| Domain | Alpha_adaptinC2 | 1.46e-05 | 9 | 106 | 3 | SM00809 | |
| Domain | VHS | 1.46e-05 | 9 | 106 | 3 | SM00288 | |
| Domain | VHS_dom | 1.46e-05 | 9 | 106 | 3 | IPR002014 | |
| Domain | SPEC | 3.12e-05 | 32 | 106 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.12e-05 | 32 | 106 | 4 | IPR018159 | |
| Domain | Coatomer/clathrin_app_Ig-like | 3.77e-05 | 12 | 106 | 3 | IPR013041 | |
| Domain | Unc-13 | 9.54e-05 | 3 | 106 | 2 | IPR027080 | |
| Domain | Spectrin | 2.90e-04 | 23 | 106 | 3 | PF00435 | |
| Domain | Munc13_dom-2 | 3.16e-04 | 5 | 106 | 2 | IPR014772 | |
| Domain | MHD2 | 3.16e-04 | 5 | 106 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 3.16e-04 | 5 | 106 | 2 | IPR019558 | |
| Domain | Membr_traf_MHD | 3.16e-04 | 5 | 106 | 2 | PF10540 | |
| Domain | DUF1041 | 3.16e-04 | 5 | 106 | 2 | SM01145 | |
| Domain | - | 4.20e-04 | 26 | 106 | 3 | 1.25.40.90 | |
| Domain | ENTH_VHS | 5.83e-04 | 29 | 106 | 3 | IPR008942 | |
| Domain | Spectrin_repeat | 5.83e-04 | 29 | 106 | 3 | IPR002017 | |
| Domain | Munc13_1 | 6.58e-04 | 7 | 106 | 2 | IPR014770 | |
| Domain | MHD1 | 6.58e-04 | 7 | 106 | 2 | PS51258 | |
| Domain | DUF1041 | 6.58e-04 | 7 | 106 | 2 | PF06292 | |
| Domain | CAPS_dom | 6.58e-04 | 7 | 106 | 2 | IPR010439 | |
| Domain | EF_HAND_2 | 2.05e-03 | 231 | 106 | 6 | PS50222 | |
| Domain | EFh | 2.07e-03 | 158 | 106 | 5 | SM00054 | |
| Domain | EF_hand_dom | 2.09e-03 | 232 | 106 | 6 | IPR002048 | |
| Domain | - | 2.78e-03 | 169 | 106 | 5 | 3.40.50.720 | |
| Domain | NAD(P)-bd_dom | 3.07e-03 | 173 | 106 | 5 | IPR016040 | |
| Domain | P-loop_NTPase | CACNB2 ABCA2 MYH11 NLRP7 DAPK1 ZFYVE1 DDX10 DMC1 PALS1 NLRP10 SULT6B1 ABCD4 | 3.11e-03 | 848 | 106 | 12 | IPR027417 |
| Domain | - | 3.74e-03 | 261 | 106 | 6 | 1.10.238.10 | |
| Domain | adh_short | 3.76e-03 | 55 | 106 | 3 | PF00106 | |
| Domain | C1_1 | 4.16e-03 | 57 | 106 | 3 | PF00130 | |
| Domain | PH | 5.08e-03 | 278 | 106 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 5.17e-03 | 279 | 106 | 6 | PS50003 | |
| Domain | PH_domain | 5.26e-03 | 280 | 106 | 6 | IPR001849 | |
| Domain | - | 5.67e-03 | 20 | 106 | 2 | 3.30.565.10 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 2.32e-05 | 189 | 88 | 8 | MM14772 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.73e-05 | 10 | 88 | 3 | MM15112 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 3.23e-05 | 198 | 88 | 8 | M18311 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | UNC13B CACNB2 GIT1 ADCY2 SLC1A6 SHANK2 KCNMA1 SYT1 PRKX CACNA2D3 | 2.36e-04 | 411 | 88 | 10 | M735 |
| Pathway | REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION | 2.48e-04 | 20 | 88 | 3 | MM14888 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 2.71e-04 | 92 | 88 | 5 | MM14881 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 2.79e-04 | 270 | 88 | 8 | M15514 | |
| Pathway | REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION | 3.80e-04 | 23 | 88 | 3 | M27174 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 3.99e-04 | 100 | 88 | 5 | M27158 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 4.33e-04 | 24 | 88 | 3 | MM14834 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 4.33e-04 | 24 | 88 | 3 | M630 | |
| Pubmed | GPD2 CACNB2 MYH11 GIT1 SPTA1 SPTB DAPK1 CDC42BPB ARPC2 TARS3 FASN SHANK2 SACS UGP2 SYT1 RIMBP2 ALB FERMT2 AP3D1 CACNA2D3 | 1.57e-08 | 1431 | 108 | 20 | 37142655 | |
| Pubmed | Mammalian GGAs act together to sort mannose 6-phosphate receptors. | 2.91e-08 | 3 | 108 | 3 | 14638859 | |
| Pubmed | Impaired nuclear import and viral incorporation of Vpr derived from a HIV long-term non-progressor. | 2.91e-08 | 3 | 108 | 3 | 18638397 | |
| Pubmed | Defects in cellular sorting and retroviral assembly induced by GGA overexpression. | 2.91e-08 | 3 | 108 | 3 | 19788741 | |
| Pubmed | Inactivation of the three GGA genes in HeLa cells partially compromises lysosomal enzyme sorting. | 2.91e-08 | 3 | 108 | 3 | 33206455 | |
| Pubmed | Regulation of α2B-Adrenergic Receptor Cell Surface Transport by GGA1 and GGA2. | 1.16e-07 | 4 | 108 | 3 | 27901063 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 15345724 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 17494868 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 10747089 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 10749927 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 18326732 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 6234993 | ||
| Pubmed | GGA proteins mediate the recycling pathway of memapsin 2 (BACE). | 1.16e-07 | 4 | 108 | 3 | 15615712 | |
| Pubmed | Analysis of the interaction between GGA1 GAT domain and Rabaptin-5. | 1.16e-07 | 4 | 108 | 3 | 16473621 | |
| Pubmed | The GGAs promote ARF-dependent recruitment of clathrin to the TGN. | 2.90e-07 | 5 | 108 | 3 | 11301005 | |
| Pubmed | GGA3 mediates TrkA endocytic recycling to promote sustained Akt phosphorylation and cell survival. | 2.90e-07 | 5 | 108 | 3 | 26446845 | |
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 25195858 | ||
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 14567678 | ||
| Pubmed | Structural basis for acidic-cluster-dileucine sorting-signal recognition by VHS domains. | 2.90e-07 | 5 | 108 | 3 | 11859375 | |
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 26053850 | ||
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 24407285 | ||
| Pubmed | Analysis of Gga null mice demonstrates a non-redundant role for mammalian GGA2 during development. | 2.90e-07 | 5 | 108 | 3 | 22291915 | |
| Pubmed | Sorting of mannose 6-phosphate receptors mediated by the GGAs. | 2.90e-07 | 5 | 108 | 3 | 11387475 | |
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 29358589 | ||
| Pubmed | GGA and Arf proteins modulate retrovirus assembly and release. | 2.90e-07 | 5 | 108 | 3 | 18439901 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | UNC13B ABCA2 WNT7B AKNA JADE1 CDC42BPB REXO1 GGA3 JUND FASN LLGL2 SHANK2 KLHL36 INTS11 GGA1 AP3D1 | 3.18e-07 | 1105 | 108 | 16 | 35748872 |
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 10814529 | ||
| Pubmed | Monoubiquitylation of GGA3 by hVPS18 regulates its ubiquitin-binding ability. | 5.78e-07 | 6 | 108 | 3 | 16996030 | |
| Pubmed | Cooperation of GGAs and AP-1 in packaging MPRs at the trans-Golgi network. | 5.78e-07 | 6 | 108 | 3 | 12215646 | |
| Pubmed | 5.78e-07 | 6 | 108 | 3 | 15039775 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MID2 CAMP SHMT1 IDH1 CDC42BPB BGN ARPC2 S100A8 PALS1 MELTF FASN EYS UGP2 ALB CCDC180 | 6.05e-07 | 1016 | 108 | 15 | 19056867 |
| Pubmed | 7.77e-07 | 101 | 108 | 6 | 18519826 | ||
| Pubmed | Human immunodeficiency virus type-1 gag and host vesicular trafficking pathways. | 8.91e-07 | 24 | 108 | 4 | 20012524 | |
| Pubmed | Tollip and Tom1 form a complex and recruit ubiquitin-conjugated proteins onto early endosomes. | 1.01e-06 | 7 | 108 | 3 | 15047686 | |
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 11390366 | ||
| Pubmed | 1.01e-06 | 7 | 108 | 3 | 11950392 | ||
| Pubmed | Divalent interaction of the GGAs with the Rabaptin-5-Rabex-5 complex. | 1.01e-06 | 7 | 108 | 3 | 12505986 | |
| Pubmed | Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release. | 1.25e-06 | 26 | 108 | 4 | 17124501 | |
| Pubmed | MYH11 NLRP7 SPTA1 RDH12 APOB ZNF318 ARPC2 PDIA4 FASN SHANK2 RDH11 SACS UGP2 IFT122 MLPH AP3D1 TOP2B | 2.23e-06 | 1442 | 108 | 17 | 35575683 | |
| Pubmed | Definition of the consensus motif recognized by gamma-adaptin ear domains. | 2.41e-06 | 9 | 108 | 3 | 14665628 | |
| Pubmed | Linkage mapping of 40 randomly isolated liver cDNA clones in the mouse. | 4.08e-06 | 76 | 108 | 5 | 8288233 | |
| Pubmed | Molecular and functional architecture of striatal dopamine release sites. | 4.72e-06 | 11 | 108 | 3 | 34767769 | |
| Pubmed | 4.72e-06 | 11 | 108 | 3 | 10747088 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MYH11 CAMP SHMT1 APOB IDH1 BGN ARPC2 S100A8 PALS1 MELTF FASN UGP2 ALB MLPH | 5.95e-06 | 1070 | 108 | 14 | 23533145 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | GPD2 CACNB2 ABCA2 MYH11 SPTA1 DAPK1 IDH1 ARPC2 PDIA4 FASN LLGL2 AP3D1 | 8.18e-06 | 807 | 108 | 12 | 30575818 |
| Pubmed | Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals. | 9.55e-06 | 2 | 108 | 2 | 25359276 | |
| Pubmed | Allelic polymorphism of KIR2DL2/2DL3 in a southern Chinese population. | 9.55e-06 | 2 | 108 | 2 | 26423800 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 7633447 | ||
| Pubmed | Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C. | 9.55e-06 | 2 | 108 | 2 | 33846289 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22762444 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 1391962 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20875478 | ||
| Pubmed | Chaperone activity and prodan binding at the self-associating domain of erythroid spectrin. | 9.55e-06 | 2 | 108 | 2 | 15492010 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 8102379 | ||
| Pubmed | Man to mouse--lessons learned from the distal end of the human X chromosome. | 9.55e-06 | 2 | 108 | 2 | 9414316 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 9414314 | ||
| Pubmed | Profiles of PrKX expression in developmental mouse embryo and human tissues. | 9.55e-06 | 2 | 108 | 2 | 15879576 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 9005995 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 7104494 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12894219 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 6215583 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15248031 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23686481 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23064941 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 3580577 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 7883966 | ||
| Pubmed | Retinol dehydrogenase 12 detoxifies 4-hydroxynonenal in photoreceptor cells. | 9.55e-06 | 2 | 108 | 2 | 19686838 | |
| Pubmed | Munc13-independent vesicle priming at mouse photoreceptor ribbon synapses. | 9.55e-06 | 2 | 108 | 2 | 22674279 | |
| Pubmed | Spectrin Cosenza: a novel beta chain variant associated with Sp alphaI/74 hereditary elliptocytosis. | 9.55e-06 | 2 | 108 | 2 | 9163587 | |
| Pubmed | No association of DAPK1 and ABCA2 SNPs on chromosome 9 with Alzheimer's disease. | 9.55e-06 | 2 | 108 | 2 | 18336955 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 8018926 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 21684272 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 9302280 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17130236 | ||
| Pubmed | KIR2DL2/2DL3-E(35) alleles are functionally stronger than -Q(35) alleles. | 9.55e-06 | 2 | 108 | 2 | 27030405 | |
| Pubmed | Erythrocyte spectrin is comprised of many homologous triple helical segments. | 9.55e-06 | 2 | 108 | 2 | 6472478 | |
| Pubmed | RIM-BP2 primes synaptic vesicles via recruitment of Munc13-1 at hippocampal mossy fiber synapses. | 9.55e-06 | 2 | 108 | 2 | 31535974 | |
| Pubmed | Identification of the proteoglycan binding site in apolipoprotein B48. | 9.55e-06 | 2 | 108 | 2 | 12070165 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 2070088 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 9373273 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 30198572 | ||
| Pubmed | Spectrin mutations in hereditary elliptocytosis and hereditary spherocytosis. | 9.55e-06 | 2 | 108 | 2 | 8844207 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 2056132 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 2346784 | ||
| Pubmed | GGA proteins bind ubiquitin to facilitate sorting at the trans-Golgi network. | 9.55e-06 | 2 | 108 | 2 | 15039776 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17197551 | ||
| Pubmed | Exome sequencing: an efficient diagnostic tool for complex neurodegenerative disorders. | 9.55e-06 | 2 | 108 | 2 | 23043354 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 22715396 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 8226774 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 1634521 | ||
| Pubmed | Glycosylation of erythrocyte spectrin and its modification in visceral leishmaniasis. | 9.55e-06 | 2 | 108 | 2 | 22164239 | |
| Pubmed | A novel murine PKA-related protein kinase involved in neuronal differentiation. | 9.55e-06 | 2 | 108 | 2 | 10729225 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20197550 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17977835 | ||
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 2.30e-05 | 18 | 108 | 3 | 12119179 | |
| Pubmed | 2.67e-05 | 382 | 108 | 8 | 37249651 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 17596511 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 30696053 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 22621924 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 20585040 | ||
| GeneFamily | Golgi associated, gamma adaptin ear containing, ARF binding proteins | 6.86e-08 | 3 | 75 | 3 | 1031 | |
| GeneFamily | EF-hand domain containing|Spectrins | 2.37e-06 | 7 | 75 | 3 | 1113 | |
| GeneFamily | UNC13 homologs | 1.01e-04 | 4 | 75 | 2 | 836 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 2.80e-04 | 76 | 75 | 4 | 743 | |
| GeneFamily | EF-hand domain containing | 2.96e-04 | 219 | 75 | 6 | 863 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 2.49e-03 | 18 | 75 | 2 | 620 | |
| GeneFamily | NLR family | 4.79e-03 | 25 | 75 | 2 | 666 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 4.79e-03 | 25 | 75 | 2 | 994 | |
| GeneFamily | Calcium voltage-gated channel subunits | 5.17e-03 | 26 | 75 | 2 | 253 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 5.17e-03 | 26 | 75 | 2 | 904 | |
| Coexpression | GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP | 7.31e-07 | 177 | 108 | 8 | M5641 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.75e-05 | 65 | 105 | 5 | gudmap_developingGonad_e12.5_epididymis_k2_1000 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-07 | 177 | 108 | 7 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.01e-07 | 181 | 108 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-07 | 184 | 108 | 7 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.61e-07 | 186 | 108 | 7 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.61e-07 | 186 | 108 | 7 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.75e-07 | 187 | 108 | 7 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 4.03e-07 | 189 | 108 | 7 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-07 | 196 | 108 | 7 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 5.51e-07 | 198 | 108 | 7 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 5.51e-07 | 198 | 108 | 7 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.89e-07 | 200 | 108 | 7 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.89e-07 | 200 | 108 | 7 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.58e-06 | 169 | 108 | 6 | 8c96e1baa38ec5e777e627ab9dbce025e771f2c0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.58e-06 | 169 | 108 | 6 | 86041be5d3aeab5b9269f7912791b944f325a1b4 | |
| ToppCell | Healthy-Plasmablast|World / disease group, cell group and cell class | 4.24e-06 | 174 | 108 | 6 | 6becb456d8f44a1224c6d42be78d4c8cdb51f199 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.38e-06 | 175 | 108 | 6 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-06 | 178 | 108 | 6 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.99e-06 | 179 | 108 | 6 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.02e-06 | 185 | 108 | 6 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.21e-06 | 186 | 108 | 6 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.60e-06 | 188 | 108 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | facs-Skin-Anagen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-06 | 189 | 108 | 6 | adbfc723130079b4caf551f66d2aee86fab1903c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.01e-06 | 190 | 108 | 6 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-06 | 190 | 108 | 6 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-06 | 190 | 108 | 6 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-06 | 190 | 108 | 6 | 888ded899f0513d41bf655896d59ae8ef74e0978 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-06 | 190 | 108 | 6 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-06 | 190 | 108 | 6 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | facs-Skin-Anagen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-06 | 190 | 108 | 6 | 3466cebab16964e94da130d0673fa32e7d90b5ed | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 7.01e-06 | 190 | 108 | 6 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.23e-06 | 191 | 108 | 6 | fd8331c7abdd999f55ba43d307945c6abfccbf84 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.23e-06 | 191 | 108 | 6 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.45e-06 | 192 | 108 | 6 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.60e-06 | 111 | 108 | 5 | dfbdeadad321392d359e6fb7112b28b043a4b874 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 7.67e-06 | 193 | 108 | 6 | e790ab76c12f74a13936c231076f1e397283efb3 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 7.90e-06 | 194 | 108 | 6 | 7773501e076d470158dbc1d7f10c67152b326eb7 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK|blood / Manually curated celltypes from each tissue | 8.14e-06 | 195 | 108 | 6 | c1db871e8e8e8b8d6a5798bc43eaf54e102b75eb | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.14e-06 | 195 | 108 | 6 | c6bb16c0076639c6ddef1a15d8cba44bc29c077d | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.14e-06 | 195 | 108 | 6 | ea89f80d3d7e9f737442f7c1aa1791d277ffc90c | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.62e-06 | 197 | 108 | 6 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.13e-06 | 199 | 108 | 6 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.13e-06 | 199 | 108 | 6 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.13e-06 | 199 | 108 | 6 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.13e-06 | 199 | 108 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.13e-06 | 199 | 108 | 6 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.13e-06 | 199 | 108 | 6 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|Control_saline / Treatment groups by lineage, cell group, cell type | 9.13e-06 | 199 | 108 | 6 | 86d4e5dd3bcc6bafa48fd0211dad39a2456b53be | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.13e-06 | 199 | 108 | 6 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.40e-06 | 200 | 108 | 6 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | f99e214eb680fd82a33f2b1524fbfca265d1cc42 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | d85074b362b11e5a523a5325d203a61aa2759a7a | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.40e-06 | 200 | 108 | 6 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 148 | 108 | 5 | 5c853637f6058f78608ba0e76cda72a548d40710 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 148 | 108 | 5 | 763c598826445bf627989220cd7acd71c4f1ea36 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 148 | 108 | 5 | d3f224128593251b72429a1cd52e82f77df8e386 | |
| ToppCell | droplet-Heart-nan-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 158 | 108 | 5 | 81a5a73090804d41429d297ba2462a842f39d380 | |
| ToppCell | droplet-Heart-nan-18m-Myeloid-cardiac_mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 158 | 108 | 5 | 9596b7b0f6f5157a43d67d2e67fb75a2624a6bb9 | |
| ToppCell | droplet-Heart-nan-18m-Myeloid-mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 158 | 108 | 5 | 7ebc8b778c97c0faa79e2d80c98b887fa635f901 | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.17e-05 | 158 | 108 | 5 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-neutrophil-neutrophil|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.30e-05 | 159 | 108 | 5 | be54b910ccb73e37eb81945bbad9a89d2bcec34b | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-neutrophil|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.30e-05 | 159 | 108 | 5 | 178678173b005cb8225472306657f0d8289b133b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 160 | 108 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 160 | 108 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.57e-05 | 161 | 108 | 5 | 1e17a993126e1f2a25ee7dfbb95a74ccb2a26791 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-neutrophil|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.70e-05 | 162 | 108 | 5 | f24eb596653180040bfdefad9c246fc42cbfaac8 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-neutrophil-neutrophil|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.70e-05 | 162 | 108 | 5 | 1a953e165b7e469815294728350ec13d27c9bd9d | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 163 | 108 | 5 | 57f02f2b9ce940a2962bb57cd8d02eb67b6f44a3 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 163 | 108 | 5 | 155ac52a34e0d55545aab8a3e4162fc4c387e697 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-05 | 163 | 108 | 5 | c132fb5b56186a10d33ae5ce17b2a7e670d52f79 | |
| ToppCell | LPS-antiTNF-Epithelial_airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.28e-05 | 166 | 108 | 5 | eb942ed68677e55c46cb039046f45686d4062d7c | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 166 | 108 | 5 | a1211afc1197d078eb3db0d0f788ecaf4419aa5b | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.43e-05 | 167 | 108 | 5 | 7efa0081e79f22b219eac64ffcaedb2179cde299 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.43e-05 | 167 | 108 | 5 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 5.59e-05 | 168 | 108 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 5.91e-05 | 170 | 108 | 5 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.91e-05 | 170 | 108 | 5 | dbd6c9c7be824a1ff1b31af791064127cafbd194 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.42e-05 | 173 | 108 | 5 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.42e-05 | 173 | 108 | 5 | f8e3dded726bb3a6c24bfedf8c6732bb46262308 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-05 | 174 | 108 | 5 | 723848d2f8ae9cf4f15d4b4a130f9a64dab443c7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-05 | 175 | 108 | 5 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.78e-05 | 175 | 108 | 5 | 182e45f5c02214d6b9f317ff5dc43af8b42de978 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.78e-05 | 175 | 108 | 5 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 6.96e-05 | 176 | 108 | 5 | 8513c2a05a34453a16bbcf1c11cb34c580133e47 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.15e-05 | 177 | 108 | 5 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.15e-05 | 177 | 108 | 5 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ|normal_Lymph_Node / Location, Cell class and cell subclass | 7.35e-05 | 178 | 108 | 5 | d75057e7463558a0d3cebde3c30befbf4704dd9a | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Definitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.16e-05 | 182 | 108 | 5 | 93841f730ca1a735eaaf5f2ccbe5c45ab0e029d1 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-05 | 182 | 108 | 5 | 41f1749e2368397bca49143786da0423792f03bd | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.16e-05 | 182 | 108 | 5 | cc79e0cc21e2fdc4ef77f052818d27b9f707aec1 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.37e-05 | 183 | 108 | 5 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 8.37e-05 | 183 | 108 | 5 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| Drug | Sulpiride [15676-16-1]; Up 200; 11.8uM; HL60; HG-U133A | 4.05e-07 | 196 | 108 | 9 | 1967_UP | |
| Drug | prodan | 4.14e-07 | 4 | 108 | 3 | ctd:C038517 | |
| Drug | verapamil | CACNB2 ABCA2 MYH11 APOB ADCY2 ABCD4 KCNMA1 SCNN1G DIXDC1 ALB TOP2B CACNA2D3 | 3.71e-06 | 490 | 108 | 12 | CID000002520 |
| Drug | Talampicillin hydrochloride [39878-70-1]; Up 200; 7.8uM; HL60; HT_HG-U133A | 4.58e-06 | 197 | 108 | 8 | 2954_UP | |
| Drug | Guanidine | 5.71e-06 | 8 | 108 | 3 | ctd:D019791 | |
| Drug | ethanol | GPD2 CACNB2 SPTA1 SPTB APOB ADCY2 DDX10 PDIA4 SPTBN5 JUND KCNMA1 SCNN1G SYT1 ALB GPSM1 | 9.69e-06 | 837 | 108 | 15 | CID000000702 |
| Disease | Leber congenital amaurosis (implicated_via_orthology) | 1.22e-05 | 13 | 105 | 3 | DOID:14791 (implicated_via_orthology) | |
| Disease | lysosomal storage disease (implicated_via_orthology) | 2.37e-05 | 16 | 105 | 3 | DOID:3211 (implicated_via_orthology) | |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.23e-05 | 447 | 105 | 9 | EFO_0000694, MONDO_0100096 | |
| Disease | Hereditary elliptocytosis | 7.49e-05 | 4 | 105 | 2 | cv:C0013902 | |
| Disease | hereditary spherocytosis (is_implicated_in) | 1.25e-04 | 5 | 105 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | Hereditary spherocytosis | 1.25e-04 | 5 | 105 | 2 | cv:C0037889 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 1.25e-04 | 5 | 105 | 2 | C0221409 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.74e-04 | 145 | 105 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | Respiratory Tract Diseases | 1.86e-04 | 6 | 105 | 2 | C0035242 | |
| Disease | Elliptocytosis, Hereditary | 1.86e-04 | 6 | 105 | 2 | C0013902 | |
| Disease | obsolete_red blood cell distribution width | DPY19L3 IRF2BP1 SPTA1 SPTB SHMT1 ARMH1 APOB ZFYVE1 F8 REXO1 ARPC2 PRIM1 GPSM1 TMEM40 | 3.01e-04 | 1347 | 105 | 14 | EFO_0005192 |
| Disease | Hereditary spherocytosis | 3.46e-04 | 8 | 105 | 2 | C0037889 | |
| Disease | Retinal Dystrophies | 3.46e-04 | 8 | 105 | 2 | C0854723 | |
| Disease | cancer (implicated_via_orthology) | 4.03e-04 | 268 | 105 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | pyoderma gangrenosum | 4.44e-04 | 9 | 105 | 2 | EFO_0006835 | |
| Disease | metabolic rate measurement | 6.76e-04 | 11 | 105 | 2 | EFO_0005115 | |
| Disease | inflammatory biomarker measurement, YKL40 measurement | 8.05e-04 | 51 | 105 | 3 | EFO_0004869, EFO_0004872 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.05e-03 | 125 | 105 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.05e-03 | 125 | 105 | 4 | C1879321 | |
| Disease | Leber congenital amaurosis | 1.46e-03 | 16 | 105 | 2 | cv:C0339527 | |
| Disease | Malignant neoplasm of breast | RB1 MCF2L2 SHMT1 ZNF318 CHEK1 BGN GGA3 DDX10 FASN LLGL2 GGA1 | 1.55e-03 | 1074 | 105 | 11 | C0006142 |
| Disease | Manic Disorder | 2.10e-03 | 71 | 105 | 3 | C0024713 | |
| Disease | Retinitis pigmentosa | 2.36e-03 | 74 | 105 | 3 | cv:C0035334 | |
| Disease | Retinal Degeneration | 2.52e-03 | 21 | 105 | 2 | C0035304 | |
| Disease | Manic | 2.74e-03 | 78 | 105 | 3 | C0338831 | |
| Disease | Leber Congenital Amaurosis | 2.77e-03 | 22 | 105 | 2 | C0339527 | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 2.77e-03 | 22 | 105 | 2 | EFO_0009312 | |
| Disease | epilepsy (implicated_via_orthology) | 2.78e-03 | 163 | 105 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Depression, Bipolar | 2.85e-03 | 79 | 105 | 3 | C0005587 | |
| Disease | Coronary heart disease | 3.29e-03 | 24 | 105 | 2 | C0010068 | |
| Disease | glioblastoma (is_implicated_in) | 3.29e-03 | 24 | 105 | 2 | DOID:3068 (is_implicated_in) | |
| Disease | Dyslipidemias | 3.29e-03 | 24 | 105 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 3.29e-03 | 24 | 105 | 2 | C0598784 | |
| Disease | Leukemia, Myelocytic, Acute | 3.44e-03 | 173 | 105 | 4 | C0023467 | |
| Disease | memory performance | 3.48e-03 | 409 | 105 | 6 | EFO_0004874 | |
| Disease | squamous cell lung carcinoma, family history of lung cancer | 3.50e-03 | 85 | 105 | 3 | EFO_0000708, EFO_0006953 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EEGLNKAIHYFRKEL | 381 | Q8NBZ7 | |
| FRKGHQDLLVFDADK | 356 | Q8NAT2 | |
| DFGLAHKIDFGNEFK | 161 | P53355 | |
| VAHRFKDLGEENFKA | 31 | P02768 | |
| FRLSKGDGLEFKRHF | 441 | O14757 | |
| DNAGKVARSHILDKF | 21 | Q6PIY5 | |
| LKFYKELQAHGADEL | 61 | O15144 | |
| TLKDFKAAIDREGNH | 626 | Q155Q3 | |
| EGKRFLELGKEEDFH | 611 | Q9Y2X7 | |
| KFADGKLLFHNAALL | 536 | O60423 | |
| DEHIFKFLKAKFGLG | 371 | Q6ZPD9 | |
| KLVHQEKLEGDFRFK | 211 | O14678 | |
| ILEIKKQLRAGFFEH | 871 | Q9P1Z9 | |
| VAAKFHEEAGIFKLL | 206 | Q14565 | |
| QKALFDFLKHRFEGR | 301 | Q08289 | |
| KNDEGATHEKLDFRL | 1026 | O14617 | |
| LKNKDLDARLFLDHD | 326 | P06400 | |
| QGKIFAFDLDAKRLA | 251 | Q96P11 | |
| RAFAEGFLAEEKQLH | 106 | Q96NR8 | |
| EHLAKQGNRFHFDIK | 226 | Q9H4B0 | |
| EEKGKITFADFHRFA | 466 | Q8NF37 | |
| EHFLLHREGKFKDTL | 56 | P43627 | |
| KRLDAFIDGFILNHF | 161 | Q8N4N3 | |
| RFHKFDADQKGFITI | 631 | P43304 | |
| LFNEDFNKKHFRAGA | 206 | Q96LI6 | |
| DRFEEAQKAFHKAGR | 876 | Q9HBG6 | |
| NKEFFIIDEARHGKN | 2316 | Q5T1H1 | |
| VSNFLKDFLHKDRDD | 421 | Q12791 | |
| LKRDLFQFNKTVEHG | 16 | Q6P1M3 | |
| QVHGKKLFLRFDLDE | 46 | Q969S2 | |
| EFKHIKAFDRAFADN | 301 | Q5TA45 | |
| QHFLLHREGKFKDTL | 56 | P43628 | |
| FLFEEAELRKHNLDG | 426 | Q86W26 | |
| FHKERLAIAKEFGDK | 231 | Q86YR5 | |
| FAEGFVKALEDLHKQ | 136 | P17535 | |
| AAIRFKDLKNFHVDL | 136 | Q8N5G2 | |
| DILGKSLEFHRQLDK | 421 | Q86YR7 | |
| KYLFDLLDELAEKHG | 1726 | Q9ULL4 | |
| DISELRKDDFKGLQH | 101 | P21810 | |
| FHDEVGKFRFLNELI | 81 | Q9UJY5 | |
| KFHSEVAKFRFLNEL | 96 | Q9UJY4 | |
| HNEVGKFRFLNELIK | 81 | Q9NZ52 | |
| LHKFILLFAVFDEGK | 211 | P00451 | |
| NGIEDFKKHAFFEGL | 331 | Q9Y5S2 | |
| FEKDFRTIGNLHLHK | 121 | Q9H999 | |
| AAGKFIEHGEFEKNL | 541 | Q8N3R9 | |
| IIDRALKEDFGFKHR | 141 | P49642 | |
| EHFLENLDKSRKGEL | 396 | P49642 | |
| SFFEKLKHQDGIRNL | 131 | Q9BWT3 | |
| DFFKALGRVKQIHND | 181 | Q9Y2V7 | |
| FAFALVGKLDAINKH | 976 | Q08462 | |
| REHNAKFSLDGKAAL | 1691 | P04114 | |
| LGFDVKRKDFLAHII | 196 | Q8IU89 | |
| AHRAKLDNNKELAFF | 341 | O75874 | |
| RHKKFDEFFRELLEN | 101 | Q9Y625 | |
| EFRAHVAKKLGALLD | 81 | Q96C57 | |
| EHFREHLDKLFAKGI | 321 | Q8IZS8 | |
| FLKAGDKENIFNADH | 751 | Q8IZS8 | |
| EAAKKGAFERLFQHL | 1281 | Q9BZC7 | |
| KGFQRLKAAHAALEE | 596 | Q7Z591 | |
| KHKGRVLRDFFDSLN | 286 | P48664 | |
| DKDNKRFALLGDFFR | 126 | P49913 | |
| AHLKKADEANDNLFR | 321 | P09913 | |
| DFKEKFQHKLGRVLD | 486 | Q8N7U6 | |
| EDADFLKVKRHNVFG | 631 | Q13206 | |
| FRSGQGKDLDFHKLE | 1836 | Q8NDH2 | |
| THFIARFQGGKKEEL | 571 | Q96AC1 | |
| KKDHRDNLEFFLAGI | 786 | P49327 | |
| FHAFDKDGDGIIKLN | 796 | P20807 | |
| LIFDQDEKGKARDFF | 161 | P51170 | |
| DHLNEGKDSFRALKF | 1261 | Q9NZJ4 | |
| FKKDHGLVGRVFAFD | 246 | Q8IU81 | |
| KKRLLSVHDFDFEGD | 186 | Q9BV36 | |
| RGLLEKDFQKVAHFI | 411 | P34896 | |
| DFDRFSKHDIIGEFK | 231 | P21579 | |
| DHRKIGKEQELFFFH | 401 | A2RTX5 | |
| LKKRALSHADLFGDE | 511 | Q8N1G1 | |
| SIRAFAKGFLAEEKH | 106 | Q8TC12 | |
| RDLEKFRQHAGKIDL | 56 | O15034 | |
| FDGQALLHKFDFKEG | 61 | Q16518 | |
| DFQHVEKLNLGAFEK | 56 | Q9UGK3 | |
| KHLDGDNVKFILYED | 191 | Q6IMI4 | |
| LIKGNFHAVYRDDLK | 21 | P05109 | |
| EKLAQAEAAGLHKVF | 996 | Q02880 | |
| LLDKAQDLFGDDHNK | 641 | P08582 | |
| DRDGHIKLTDFGFAK | 181 | O43930 | |
| FLFGLANEKRAKELE | 521 | Q8WX94 | |
| KFEGGDRDLEHLSKF | 616 | P13667 | |
| DNRFHCDLIKGDLKD | 661 | Q6IE81 | |
| FQEIGKDDRHKNIFF | 16 | Q96P63 | |
| FQHKAALRESFLKDA | 431 | Q9NRC6 | |
| ALKNGGAHLDFRAKD | 216 | Q9UPX8 | |
| LKRKLEGDASDFHEQ | 1056 | P35749 | |
| FREVGHLLKEKYNAA | 221 | P56706 | |
| HEFEHTKKDLDGFRK | 46 | Q16851 | |
| DGFRKLFHRFLQEKG | 56 | Q16851 | |
| KFLASIFDKNHERFR | 11 | Q8WVN8 | |
| RVKQHFKKESDDFLG | 1296 | Q8NB66 | |
| HGNAFFKDKQRELGD | 911 | Q96PX9 | |
| RLNIKKDDEFFHFVL | 151 | Q8WWA1 | |
| NLFRDFFLKHKIALD | 221 | Q8IZ13 | |
| LVDGFENKEFKIHLA | 361 | Q8IZ13 | |
| NFGKERFVKLLDQLH | 851 | O14795 | |
| QRKHKAFEDELRGLD | 676 | P11277 | |
| EEAAGALLKKHEAFL | 931 | P02549 | |
| DRDGHIKLTDFGFAK | 181 | P51817 | |
| DGKAHFLQLRKDFDQ | 116 | Q8IUF8 | |
| RLHNDLFKFLGDASE | 271 | Q9HBF4 | |
| GALHEDEARKKFHQL | 106 | Q9BXA7 | |
| NFALDFSREKKLLEG | 381 | Q9UJV3 | |
| LREKFGSFLCHKDNL | 466 | Q5VUA4 | |
| QLEKRDDLHYKDEGF | 131 | Q02386 | |
| HVFDKGKRDFLNLCL | 446 | A8MT70 | |
| EKGEFHKLADAKIFL | 36 | Q9UHQ1 |